SEC Form 4 · accession 0000899243-17-027391
scPharmaceuticals Inc. · SCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
SUN PHARMACEUTICAL INDUSTRIES LTD
10% Owner
Dilip S Shanghvi
10% Owner
Sun Pharma (Netherlands) B.V.
10% Owner
Sun Pharmaceutical Industries, Inc.
10% Owner
Period of report
Nov 21, 2017
Accepted (ET)
Nov 24, 2017 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 21, 2017 | C | 1,810,536 | — | A | 1,810,536 | I | By Sun Pharmaceutical Industries, Inc. |
| Common StockF3 | Nov 21, 2017 | P | 357,143 | $14.00 | A | 357,143 | I | By Sun Pharma (Netherlands) B.V. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF2,F4 | — | Nov 21, 2017 | C | 13,000,000 | D | — | — | Common Stock | 1,810,536 | 0 | I |
Explanation of responses
- F1Represents the total number of shares of Common Stock received by Sun Pharmaceutical Industries, Inc. upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
- F2Sun Pharmaceutical Industries Limited ("Sun Pharma") directly and indirectly owns all shares of Sun Pharmaceutical Industries, Inc., which is the registered owner of the securities. Sun Pharma may be deemed to beneficially own all of the shares of the Issuer held by Sun Pharmaceutical Industries, Inc. Dilip S. Shanghvi is the controlling shareholder of Sun Pharma. Sun Pharma and Mr. Shanghvi disclaim beneficial ownership of the reported shares except to the extent of their respective pecuniary interests therein.
- F3Sun Pharma is the sole shareholder of Sun Pharma (Netherlands) B.V., which is the registered owner of the securities. Sun Pharma may be deemed to beneficially own all of the shares of the Issuer held by Sun Pharma (Netherlands) B.V. Dilip S. Shanghvi is the controlling shareholder of Sun Pharma. Sun Pharma and Mr. Shanghvi disclaim beneficial ownership of the reported shares except to the extent of their respective pecuniary interests therein.
- F4All series of the Issuer's Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017. The Series B Preferred Stock had no expiration date.
Remarks
Exhibit 24 - Power of Attorney